Table 2.
HCV | |
---|---|
Age (years) | 45 ± 12 |
Sex (male) | 40% |
Years in US (years) | 7.1 ± 6.1 |
AST (U/L) | 26 (20–41) |
ALT (U/L) | 26 (18–42) |
Albumin (g/dL) | 4.8 (4.6–5.0) |
Total bilirubin (mg/dL) | 0.5 (0.4–0.6) |
Platelet count (× 109 per L)≠ | 229 ± 53 |
AFP (ng/mL) | 3 (2–4) |
Liver stiffness (kPa)* | 7.3 ± 3.8 |
FibroScan Fibrosis score F3-F4* | 15% |
CAP score* | 233 ± 58 |
FibroScan Steatosis score ≥ S2 | 31% |
FIB-4 Score≠ | 1.01 (0.74–1.34) |
Values provided as mean ± standard deviation, median (interquartile range), or column percentage.
Comparisons between groups were made by student’s t-test, Mann-Whitney U test, or chi-square analysis, as appropriate.
26 of 38 patients with available data
46 of 48 patients with available data